Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zack, M. B.
Right arrow Articles by Stein, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zack, M. B.
Right arrow Articles by Stein, E.
(Chest. 1973;63:348-352.)
© 1973 American College of Chest Physicians

Clinical Evaluation of Stabilized and Nonstabilized PPD-B in Patients with Group III Atypical Mycobacteria

Michael B. Zack M.D.; Lynn L. Fulkerson M.D., F.C.C.P.1; Gail Hartshorne B.S., R.N.2; Elgin Kennedy M.D.3; and Emunuel Stein M.D., F.C.C.P.4

1 Associate Chief, Department of Medicine, US Public Health Service Hospital, Staten Island
2 Public Health Nurse Coordinator, USPHS Hospital, Staten Island
3 General Medical Officer, US Public Health Service Hospital, Staten Island
4 Chief, Medical Education and Clinical Cardiology, US Public Health Service Hospital, Staten Island

Fifty-five individuals with positive cultures for nonchromogenic group III atypical mycobacteria were skin tested. PPD-B and PPD-B stabilized with Tween 80 to prevent glass adhesion were compared. In addition PPD-B and PPD were compared using both stabilized and nonstabilized preparations. Stabilized PPD-B was much more sensitive than nonstabilized PPD-B and there were far fewer false negatives. In this population the dual skin test procedure was of no diagnostic benefit. The results support the conclusion that enhanced biologic accuracy in a clinical setting is obtainable with stabilized intermediate strength tuberculin PPD-B.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1973 by the American College of Chest Physicians.